您要查找的是不是：
- Diabetic nephropathy model 糖尿病肾病模型
- Objective:To observe the effects of Gushen capsule on lipidic metabolism and oxygen derived free radidicals in rats model of diabetic nephropathy(DN). 目的:观察固肾胶囊对糖尿病肾病(DN)大鼠脂质代谢及氧自由基的影响。
- Conclusion GSH is effective in patients with diabetic nephropathy. 结论还原型谷胱甘肽对糖尿病肾病有一定的治疗作用。
- Diabetic nephropathy models 糖尿病肾病模型
- Phlegm and blood stasis have close related with diabetic nephropathy (DN). 摘要痰、瘀与糖尿病肾病(DN)有着密切的关系。
- This article reviews the relationship between ICAM-1 and Diabetic nephropathy. 现就ICAM-1与糖尿病肾病关系进行综述。
- Objective:To investigate the concentration of serum HGF and the expression of HGF in kidney of type 2 diabetic rat model in different stages,and to study the effect in the pathogenesis of diabetic nephropathy (DN). 目的：观察2型糖尿病大鼠模型不同阶段血清HGF水平、肾脏局部HGF的表达，探讨其在糖尿病肾病发病中的作用。
- METHODS: The rat model of diabetic nephropathy was established by using STZ.The effect of Tangmaiantai on rat blood glucose before meal, serum TC, TG, Ccr, BUN and urinary protein were observed. 方法用链脲佐菌素复制糖尿病肾病大鼠模型,观察糖脉安泰口服液对其空腹血糖、血胆固醇、甘油三脂及血肌酐、尿素氮、尿蛋白的影响。
- OBJECTIVE To investigate the effects and mechanism of puerarin and vitamin C on diabetic nephropathy(DN). 目的探讨葛根素与维生素C联合应用对糖尿病肾病(DN)的影响及机制。
- Objective To observe the clinic effect of bushenhuayu on early the type 2 diabetic nephropathy (DN). 目的：探讨补肾化瘀方对2型糖尿病肾病(diabetic nephropathy，DN)的临床疗效及作用机理。
- We considered the expression of MMP-2 was decreased in extracellular matrix(ECM)of diabetic nephropathy. 推想糖尿病肾病的肾组织的细胞外基质(ECM)的堆积与MMP-2表达降低相关。
- Objective: Diabetic nephropathy (DN) is one of the common and serious diabetic complications. 目的：糖尿病肾病（DN）是常见的糖尿病慢性微血管并发症，是导致慢性肾功能不全的常见原因之一。
- TSJN has significant preventive and therapeutic effects on diabetic nephropathy rats induced by alloxan and achromycin. 糖肾胶囊对四氧嘧啶加嘌呤霉素诱发糖尿病肾病模型大鼠有显著防治作用。
- Methods: We have established ADR nephropathy model, and measured the expression of CyP gene in ADR nephropathy by RT PCR. 方法 :应用传统的方法首先建立阿霉素肾病模型 ,通过逆转录聚合酶链反应 ( RT- PCR)测定阿霉素肾病肾组织环孢素亲合素基因的表达。
- Diabetic nephropathy (Group DN); and diabetic rats treated with irbesartan (Group DNI). 糖尿病肾病组(diabetic nephropathy，DN，Group DN):糖尿病肾病并采用血管紧张素11受体l桔抗剂一厄贝沙坦(i rbesartan，Irb)干预组(Group DNx)。
- Conclusion: CAPD to Diabetic nephropathy is secure and effective, which can be done at home.The life quality is high. 结论：CAPD治疗糖尿病肾病尿毒症安全有效，腹腔给胰岛素血糖控制良好，可在家中进行透析，患者生活质量较高。
- The symptoms of diabetic nephropathy may develop from microalbuminuria into renal failure. 糖尿病肾病的症状可以从微量白蛋白尿发展为肾功能衰竭。
- Objective To investigate the effect of losartan on urinary podocyte excretion in diabetic nephropathy (DN) patients. 摘要 目的 观测糖尿病肾病(DN)患者尿足细胞排泄特征及氯沙坦对其的干预作用。
- Objective: Observation the effect of sodium ferulate treating renal inadequacy caused by diabetic nephropathy. 目的:观察阿魏酸钠治疗糖尿病肾病肾功能不全的效果。
- Objective To study the effect of lower-molecular-weight heparin(LMWH)on diabetic nephropathy (DN). 目的观察低分子质量肝素对糖尿病肾病的治疗效果。
